Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Cougar Biotechnology (CGRB)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: CGRB
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Analysis - Latest Articles
by
most recent
|
most commented
Biotech: Q3 Market Update
Oct 16
•
R. Scott Raynovich
•
1 Comment
OncoGenex: Room for Further Growth?
Oct 8
•
EP Vantage
•
Comment!
Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer
Jun 19
•
Michael Becker
•
6 Comments
Biotech Stocks and the ASCO-Effect
Jun 1
•
Michael Becker
•
2 Comments
Big Pharma's Pheeding Phrenzy
May 28
•
Mike Huckman
•
Comment!
Access Pharma: A Smallcap Cancer Biotech Call Option Trade
May 28
•
Mike Havrilla
•
13 Comments
Q1 2009 Biotech Earnings Roundup: The Good, the Bad, and the Ugly
May 27
•
Mark Cifra
•
4 Comments
Financing Activity May Lift Cloud Hanging over Biotech Industry
May 26
•
The Burrill Report
•
Comment!
J&J Goes to Cougar Town
May 22
•
Mike Huckman
•
1 Comment
Friday's Closing Update
May 22
•
Midnight Trader
•
2 Comments
J&J Acquiring Cougar, Beefing Up Oncology Portfolio
May 22
•
Zacks.com
•
Comment!
Cougar Bio: Hunting for a Partner?
May 14
•
Zacks.com
•
Comment!
Biopharma: Instead of M&A, Think P&A
Mar 4
•
Mike Huckman
•
2 Comments
SAC Capital Portfolio Update: 37 13G Filings
Jan 15
•
Market Folly
•
Comment!
Cougar Biotechnology: Stalking Prostate Cancer
Jul 2, 2008
•
Bryan Czyzewski
•
15 Comments
Oncology Conference Countdown: What Will Pharma and Biotech Companies Report?
May 16, 2008
•
Mike Huckman
•
4 Comments